Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minjiang Chen

Showing results (261-270 of 280) with videos related to

Pageof 28
Sort By:
ACS Nano|September 29, 2024
Potentiated Calcium Carbonate with Enhanced Calcium Overload Induction and Acid Neutralization Capabilities to Boost Chemoimmunotherapy against Liver CancerLiyun Zheng, Yiming Ding, Shiji Fang, et al.
ACS Applied Materials & Interfaces|June 20, 2025
iRGD-NaGd(MoO<sub>4</sub>)<sub>2</sub>: A Tumor-Targeted Magnetic Resonance Contrast Agent Activating Immunotherapy via the cGAS-STING PathwayLing Yu, Fengkai Qiu, Yumin Hu, et al.
Frontiers in Oncology|August 23, 2021
Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor TherapyQiaoyou Weng, Junguo Hui, Hailin Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2025
Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular CarcinomaShiji Fang, Liyun Zheng, Bin Lin, et al.
Translational Lung Cancer Research|January 24, 2022
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatmentsYuequan Shi, Xiaoyan Liu, Jia Liu, et al.
BMC Cancer|April 11, 2023
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib studyXingsheng Hu, Xinge Cui, Ziping Wang, et al.
Molecular Carcinogenesis|July 6, 2025
MAZ Coordinates With HDAC1 to Promote Hepatocarcinoma Proliferation and Metastasis Through Transcriptional Repression of CSKRongfang Qiu, Weiqian Chen, Siyu Zhao, et al.
Translational Lung Cancer Research|December 10, 2025
Alectinib versus crizotinib as the first-line treatment in patients with advanced ALK-positive non-small cell lung cancer: a Chinese real-world cohort studyHaoran Zhang, Zhaozhen Wu, Tao Lu, et al.
Nature Communications|October 12, 2017
Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancerPengfei Ma, Yujie Fu, Mei-Chun Cai, et al.
ACS Applied Bio Materials|January 11, 2022
Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional TherapyMinjiang Chen, Xiaoling Xu, Gaofeng Shu, et al.
Pageof 28

Showing results (261-270 of 280) with videos related to

Sort By:
Pageof 28
ACS Nano|September 29, 2024
Potentiated Calcium Carbonate with Enhanced Calcium Overload Induction and Acid Neutralization Capabilities to Boost Chemoimmunotherapy against Liver CancerLiyun Zheng, Yiming Ding, Shiji Fang, et al.
ACS Applied Materials & Interfaces|June 20, 2025
iRGD-NaGd(MoO<sub>4</sub>)<sub>2</sub>: A Tumor-Targeted Magnetic Resonance Contrast Agent Activating Immunotherapy via the cGAS-STING PathwayLing Yu, Fengkai Qiu, Yumin Hu, et al.
Frontiers in Oncology|August 23, 2021
Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor TherapyQiaoyou Weng, Junguo Hui, Hailin Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2025
Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular CarcinomaShiji Fang, Liyun Zheng, Bin Lin, et al.
Translational Lung Cancer Research|January 24, 2022
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatmentsYuequan Shi, Xiaoyan Liu, Jia Liu, et al.
BMC Cancer|April 11, 2023
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib studyXingsheng Hu, Xinge Cui, Ziping Wang, et al.
Molecular Carcinogenesis|July 6, 2025
MAZ Coordinates With HDAC1 to Promote Hepatocarcinoma Proliferation and Metastasis Through Transcriptional Repression of CSKRongfang Qiu, Weiqian Chen, Siyu Zhao, et al.
Translational Lung Cancer Research|December 10, 2025
Alectinib versus crizotinib as the first-line treatment in patients with advanced ALK-positive non-small cell lung cancer: a Chinese real-world cohort studyHaoran Zhang, Zhaozhen Wu, Tao Lu, et al.
Nature Communications|October 12, 2017
Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancerPengfei Ma, Yujie Fu, Mei-Chun Cai, et al.
ACS Applied Bio Materials|January 11, 2022
Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional TherapyMinjiang Chen, Xiaoling Xu, Gaofeng Shu, et al.
Pageof 28